UroGen Pharma Ltd.·4

Jun 10, 3:36 PM ET

Holden Stuart 4

4 · UroGen Pharma Ltd. · Filed Jun 10, 2022

Insider Transaction Report

Form 4
Period: 2022-06-08
Transactions
  • Award

    Stock Option (right to buy)

    2022-06-08+10,00010,000 total
    Exercise: $7.06Exp: 2032-06-08Ordinary Shares (10,000 underlying)
Footnotes (1)
  • [F1]The shares underlying the stock option will vest in equal quarterly installments over a period of one year.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    SH 06102022